文献速递哮喘

呼出气一氧化氮分数在哮喘临床管理中的应用

Using Fractional Exhaled Nitric Oxide Measurement in Clinical Asthma Management.
PubMed 文献 · Chest · 2021-10-18

本综述讨论呼出气一氧化氮分数(Feno)在哮喘管理中的临床应用,从诊断到治疗选择,并描述其在国际专家指南中的地位。Feno可快速无创反映2型气道炎症程度,有助于确认哮喘诊断、指导吸入性糖皮质激素治疗、评估治疗依从性及辅助选择生物制剂,但结果受鼻息肉和吸烟等因素影响,需结合临床背景解读。

要点

  • Feno是2型气道炎症的即时替代标志物,可快速无创测量。
  • Feno可用于辅助哮喘诊断、指导ICS治疗、评估依从性和选择生物制剂。
  • Feno结果受鼻息肉、吸烟等非哮喘因素影响,需结合临床背景解读。

核心结论

  • Feno测量可作为2型气道炎症的替代指标,在哮喘诊断和治疗选择中具有临床价值,但需结合整体临床背景解读。

研究设计与样本

  • 本文为综述,讨论Feno测量在哮喘管理中的临床应用及其在国际专家指南中的位置。

主要发现

  • 多数哮喘患者表现为2型炎症,伴IL-4、IL-5和IL-13信号增加及嗜酸性粒细胞增多。
  • 2型炎症增加导致气道NO释放上调,Feno升高反映2型炎症程度加重。
  • 痰诱导识别下气道嗜酸性粒细胞可改善哮喘结局,但耗时且昂贵。
  • Feno可在临床快速测量,作为下气道炎症程度的即时替代测量。
  • Feno水平受鼻息肉和吸烟等内外因素影响,不应孤立解读。

关键数值与推荐

  • Feno测试可用于帮助确认哮喘诊断、指导吸入性糖皮质激素治疗、评估治疗依从性及辅助选择适当的生物制剂治疗。

临床怎么用

  • 在临床中可快速测量Feno以评估2型气道炎症,辅助哮喘诊断和治疗决策。
  • 解读Feno结果时应考虑鼻息肉、吸烟等影响因素,结合 broader 临床背景而非孤立判断。

局限性

  • Feno水平受多种内在和外在因素影响,包括鼻息肉和吸烟,可能干扰结果解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Asthma is a common and heterogeneous disease characterized by lower airway inflammation and airflow limitation. Critical factors in asthma management include establishing an accurate diagnosis and ensuring appropriate selection and dosage of antiinflammatory therapies. Most patients with asthma exhibit type 2 inflammation, with increased IL-4, IL-5, and IL-13 signalling, often with associated eosinophilia. Identifying lower airway eosinophilia with sputum induction improves asthma outcomes, but is time-consuming and costly. Increased type 2 inflammation leads to upregulation of nitric oxide (NO) release into the airway, with increasing fractional exhaled NO (Feno) reflecting greater type 2 inflammation. Feno can be measured easily and quickly in the clinic, offering a point-of-care surrogate measurement of the degree of lower airway inflammation. Feno testing can be used to help confirm an asthma diagnosis, to guide inhaled corticosteroid therapy, to assess adherence to treatment, and to aid selection of appropriate biologic therapy. However, Feno levels also may be influenced by a variety of intrinsic and extrinsic factors other than asthma, including nasal polyposis and cigarette smoking, and must be interpreted in the broader clinical context, rather than viewed in isolation. This review discusses the clinical application of Feno measurement in asthma care, from diagnosis to treatment selection, and describes its place in current international expert guidelines.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Rupani H, Kent BD. Using Fractional Exhaled Nitric Oxide Measurement in Clinical Asthma Management. Chest. 2021. PMID: 34673021. doi:10.1016/j.chest.2021.10.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。